LOC100132781: A Drug Target / Disease Biomarker (G100132781)
LOC100132781: A Drug Target / Disease Biomarker
LOC100132781 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a member of the LOC1001 family of proteins, which are known to play a role in intracellular signaling. LOC100132781 has been identified as a potential drug target or biomarker due to its unique expression pattern and its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the key features of LOC100132781 is its expression pattern. This protein is highly expressed in the brain and heart, and its levels are also elevated in several diseases, such as Alzheimer's disease, Parkinson's disease, and cardiomyopathy. This suggests that LOC100132781 may be involved in the development and progression of these diseases.
Another potential drug target or biomarker property of LOC100132781 is its involvement in several diseases that affect the liver. LOC100132781 has been shown to be overexpressed in individuals with nonalcoholic steatohepatitis (NASH), a common form of liver disease. Additionally, LOC100132781 has been associated with several other liver diseases, including biliary tract cancer and chronic hepatitis.
The potential drug targets for LOC100132781 may be related to its role in intracellular signaling. LOC100132781 has been shown to play a role in several intracellular signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. These pathways are involved in several cellular processes, including cell growth, differentiation, and survival. Therefore, drugs that target these pathways may be effective in treating diseases associated with LOC100132781, such as cancer, neurodegenerative diseases, and autoimmune disorders.
In addition to its potential drug target or biomarker properties, LOC100132781 is also of interest due to its unique expression pattern and its involvement in several diseases. The identification of new drug targets or biomarkers for LOC100132781 has the potential to lead to new treatments for a variety of diseases. Further research is needed to fully understand the role of LOC100132781 in disease and to develop effective treatments.
Protein Name: Cyclin Y Like 1 Pseudogene
More Common Targets
LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443
